euro-nursing-2017-scientifictracks-abstracts

94 / 99

Page 128
Notes:
conferenceseries.com
Volume 6, Issue 4 (Suppl) J Nurs Care, an open access journal
ISSN: 2167-1168 Euro Nursing 2017
October 26-28, 2017
32nd EURO
NURSING AND MEDICARE SUMMIT
October 26-28, 2017 | Paris, France
Analysis of infusion phlebitis frequency in amiodarone treatment which is applied by changing the
infusion site once in 12 hours
Yasemin Kalkan Ugurlu and Nuray Enç
Istanbul University, Turkey
Statement of the Problem: Amiodarone is used frequently to treat emergency patients who suffer from atrial fibrillation
and ventricular tachycardia. Although intravenous amiodarone treatment has many complications, previous studies found
that infusion phlebitis was the most widely observed complication. Thrombophlebitis usually occurs when high doses of
amiodarone are infused over a long period in peripheral veins. Thus, to avoid this side effect, the drug shouldn’t be administered
in a peripheral vein for a long period. The purpose of this study is to determine the influence of infusion site change once in 12
hours in peripheral intravenous amiodarone treatment upon the occurrence of infusion phlebitis.
Methodology & Theoretical Orientation: This prospective research study has been carried out with 30 patients, who are
matching the criteria of participation in the study. The study has been carried out with face to face interview and with
observational method. The data which were necessary to be taken from the unconscious patients were obtained from their files
and relatives.
Findings: It has been observed that phlebitis grew in 30% of their peripheral venous catheter, however phlebitis did not grow in
70% of them, phlebitis grew in the 7th hour in the first catheter, and it grew in the 9th hour in the second catheter. In addition, it
has been determined that 22-gauge peripheral venous catheter size is significantly influential (p<0.01) in the phlebitis growth.
Significance: Thrombophlebitis usually occurs when amiodarone is infused over a long period in peripheral veins. For
recommendation, it can be mentioned that changing the first infusion site of the patient who started amiodarone treatment
without going beyond the 7th hour after the infusion started, and changing the 2nd infusion site without going beyond the 9th
hour would provide benefit in terms of preventing phlebitis growth.
Biography
Yasemin Kalkan Ugurlu worked as a Nurse in Coronary Intensive Care Unit for 3 years. Her Master’s Thesis was about phlebitis/thrombophlebitis due to amiodarone
treatment. She is currently continuing her Doctoral studies in the Istanbul University Florence Nightingale Faculty of Nursing, Medical Nursing Department.
Yasemin Kalkan Ugurlu et al., J Nurs Care 2017, 6:4(Suppl)
DOI: 10.4172/2167-1168-C1-061